Retraction: Role of hepatitis C virus induced osteopontin in epithelial to mesenchymal transition, migration and invasion of hepatocytes (PLoS ONE (2014) 9:1 (e87464) DOI: 10.1371/journal.pone.0087464);Role of hepatitis C virus induced osteopontin in epithelial to mesenchymal transition, migration and invasion of hepatocytes

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Iqbal, Jawed ^a   McRae, Steven ^b   Mai, Thi ^a   Banaudha, Krishna ^b   Sarkar Dutta, Mehuli ^a   Waris, Gulam ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; FOCAL ADHESION KINASE; HERMES ANTIGEN; MESSENGER RNA; OSTEOPONTIN; PHOSPHOPROTEIN; PROTEIN TYROSINE KINASE; UVOMORULIN;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL SURFACE; COCULTURE; CONFOCAL MICROSCOPY; DOWNSTREAM PROCESSING; EPITHELIAL MESENCHYMAL TRANSITION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; JAPANESE (PEOPLE); LASER MICROSCOPY; LIVER CELL; LIVER CELL CARCINOMA; LIVER INJURY; METASTASIS; PATHOGENESIS; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR GROWTH; WESTERN BLOTTING; WOUND HEALING;

ANTIGENS, CD44; CARCINOMA, HEPATOCELLULAR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; OSTEOPONTIN; SIGNAL TRANSDUCTION;

EID: 84900314775     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0216026     Document Type: Erratum

References (69)

1. Di Bisceglie AM (1997) Hepatitis C and hepatocellular carcinoma. Hepatology 26 (Suppl): S34-S38.
2. Blight KJ, Kolykhalov AA, Rice CM (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290: 1972-1974.
3. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796. (Pubitemid 41021213)
4. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, et al. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci 102: 9294-9299. (Pubitemid 40923557)
5. Parkin DM, Bray F, Ferlay J, Pisani P (2002) Global cancer statistics. CA Cancer J Clin 55: 74-108.
6. Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48: 1312-1327.
7. Di Bisceglie AM, Lyra AC, Schwartz M, Reddy RK, Martin P, et al. (2003) Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 98: 2060-2063. (Pubitemid 37185806)
8. Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY, et al. (2006) Long-term outcome of resection of large hepatocellular carcinoma. Br J Surg 93: 600-606.
9. Kern MA, Breuhahn K, Schirmacher P (2002) Molecular pathogenesis of human hepatocellular carcinoma. Adv Cancer Res 86: 67-112.
10. Hassan M, Ghozlan H, Abdel-Kader O (2005) Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth. Virology 333: 324-336. (Pubitemid 40250116)
11. Kasprzak A, Adamek A, Przybyszewska W, Olejniczak K, Biczysko W, et al. (2009) p21/Wafl/Cipl cellular expression in chronic long-lasting hepatitis C: correlation with HCV proteins (C, NS3, NS5A), other cell-cycle related proteins and selected clinical data. Folia Histochem Cytobiol 47: 385-394.
12. He QQ, Cheng RX, Sun Y, Feng DY, Chen ZC, et al. (2003) Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein. World J Gastroenterol 9: 474-478. (Pubitemid 36372110)
13. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, et al. (1998) The core protein of hepatitis-C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4: 1065-1067. (Pubitemid 28417341)
14. Moradpour D, Englert C, Wakita T, Wands JR (1996) Characterization of cell lines allowing tightly regulated expression of hepatitis-C virus core protein. Virology 222: 51-63. (Pubitemid 26281358)
15. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, et al. (2001) Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61: 4365-4370. (Pubitemid 32685760)
16. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, et al. (1995) Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 22: 449-456.
17. Gong G, Waris G, Tanveer R, Siddiqui A (2001) Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci 98: 9599-9604. (Pubitemid 32769349)
18. Presser LD, Haskett A, Waris G (2011) Hepatitis C virus-induced furin and thrombo-spondin-1 activate TGF-b1: role of TGF-b1 in HCV replication. Virology 412: 284-296.
19. Rangaswami H, Bulbule A, Kundu GC (2006) Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 16: 79-87. (Pubitemid 43247403)
20. Pan HW, Ou YH, Peng SY, Liu SH, Lai PL, et al. (2003) Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer 98: 119-127.
21. Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S (2002) Overexpression of osteopontin in hepatocellular carcinoma. Pathology International 52: 19-24. (Pubitemid 34299209)
22. Senger DR, Wirth DF, Hynes RO (1979) Transformed mammalian cells secrete specific proteins and phosphoproteins. Cell 16: 885-893. (Pubitemid 9161338)
23. Oates AJ, Barraclough R, Rudland PS (1997) The role of osteopontin in tumorigenesis and metastasis. Invasion Metastasis 17: 1-15. (Pubitemid 27525063)
24. Wai PY, Kuo PC (2008) Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev 27: 103-118.
25. Patouraux S, Bonnafous S, Voican CS, Anty R, Saint-Paul MC, et al. (2012) The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One 7: e35612. doi:10.1371/journal.pone.0035612.
26. Whalen KA, Weber GF, Benjamin TL, Schaffhausen BS (2008) Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells. J Virol 82: 4946-4954. (Pubitemid 351657056)
27. Zhang X, Ye LH, Zhang XD (2010) A mutant of hepatitis B virus X protein (HBx Delta 127) enhances hepatoma cell migration via osteopontin involving 5-lipoxygenase. Acta Pharmacol Sin 31: 593-600.
28. Brown A, Islam T, Adams R, Nerle S, Kamara M, et al. (2011) Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals. J Neurovirol 17: 382-392.
29. Iqbal J, McRae S, Banaudha K, Mai T, Waris G (2013) Mechanism of HCV-induced Osteopontin and its role in epithelial to mesenchymal transition of hepatocytes. J Biol Chem [Epub ahead of print].
30. Kazanecki CC, Uzwiak DJ, Denhardt DT (2007) Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem 102: 912-924. (Pubitemid 350036931)
31. Uede T (2011) Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int 61: 265-280.
32. Wai PY, Cao PC (2004) The role of Osteopontin in tumor metastasis. J Surg Res 121: 228-241. (Pubitemid 39387464)
33. Blight KJ, McKeating JA, Rice CM (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001-14. (Pubitemid 35386984)
34. Raney AK, Milich DR, McLachlan A (1989) Characterization of hepatitis B virus major surface antigen gene transcriptional regulatory elements in differentiated hepatoma cell lines. J Virol 63: 3919-25. (Pubitemid 19205467)
35. Burdette D, Haskett A, Presser L, McRae S, Iqbal J, et al. (2012) Hepatitis C virus activates interleukin-1b via caspase-1-inflammasome complex. J Gen Virol 93: 235-246.
36. Schaefer B, Rivas-Estilla AM, Meraz-Cruz N, Reyes-Romero MA, Hernández-Nazara ZH, et al. (2003) Reciprocal modulation of matrix metalloproteinase-13 and type I collagen genes in rat hepatic stellate cells. Am J Pathol 162: 1771-1780. (Pubitemid 36613036)
37. Banaudha K, Orenstein JM, Korolnek T, St Laurent GC 3rd, Wakita T, et al. (2010) Primary hepatocyte culture supports hepatitis C virus replication: a model for infection- associated hepatocarcinogenesis. Hepatology 51: 1922-1932.
38. Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA, et al. (1996) Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 149: 293-305. (Pubitemid 26231000)
39. Zhang R, Pan X, Huang Z, Weber GF, Zhang G (2011) Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines. PLoS One 6: e23831.doi:10.1371/journal.-pone.0023831.
40. Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-687. (Pubitemid 44286000)
41. Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, et al. (2005) Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int 25: 236-241.
42. De Minicis S, Seki E, Uchinami H, Kluwe J, Zhang Y, et al. (2007) Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 132: 1937-1946. (Pubitemid 46677935)
43. Syn WK, Choi SS, Liaskou E, Karaca GF, Agboola KM, et al. (2011) Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology 53: 106-115.
44. Lee SH, Seo GS, Park YN, Yoo TM, Sohn DH (2004) Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem Pharmacol 68: 2367-2378. (Pubitemid 39535109)
45. Lorena D, Darby IA, Gadeau AP, Leen LL, Rittling S, et al. (2006) Osteopontin expression in normal and fibrotic liver altered liver healing in osteopontin-deficient mice. J Hepatol 44: 383-390. (Pubitemid 43069221)
46. Abu El Makarem MA, Abdel-Aleem A, Ali A, Saber R, Shatat M, et al. (2011) Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma. Annals of Hepatology 10: 296-305.
47. Shang S, Plymoth A, Ge S, Feng Z, Rosen HR, et al. (2012) Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology 55: 483-490.
48. Phillips RJ, Helbig KJ, Van der Hoek KH, Seth D, Beard MR (2012) Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J Gastroenterol 18: 3389-3399.
49. Sodek J, Ganss B, Mc Kee MD (2000) Osteopontin. Critical Reviews in Oral Biology and Medicine 11: 279-303.
50. Prince CW, Oosawa T, Butler WT, Tomana M, Bhown AS, et al. (1987) Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. J Biol Chem 262: 2900-2907.
51. Johnson GA, Burghardt RC, Joyce MM, Spencer TE, Bazer FW, et al. (2003) Osteopontin is synthesized by uterine glands and a 45-kDa cleavage fragment is localized at the uterine-placental interface throughout ovine pregnancy. Biol Reprod 69: 92-98. (Pubitemid 36806811)
52. Takafuji V, Forgues M, Unsworth E, Goldsmith P, Wang XW (2007) An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene 26: 6361-6371. (Pubitemid 47494216)
53. Kim HJ, Lee HJ, Jun JI, Oh Y, Choi SG, et al. (2009) Intracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53. Proc Natl Acad Sci 106: 15326-15331.
54. Kikuchi S, Griffin CT, Wang SS, Bissell DM (2005) Role of CD44 in epithelial wound repair: migration of rat hepatic stellate cells utilizes hyaluronic acid and CD44v6. J Biol Chem 280: 15398-15404. (Pubitemid 40562897)
55. Furger KA, Allan AL, Wilson SM, Hota C, Vantyghem SA, et al. (2003) Beta (3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin. Mol Cancer Res 1: 810-819. (Pubitemid 37174452)
56. Christensen B, Schack L, Kläning E, Sørensen ES (2010) Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D. J Biol Chem 285: 7929-7937.
57. Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271: 509-512. (Pubitemid 26044470)
58. Zou C, Luo Q, Qin J, Shi Y, Yang L, et al. (2013) Osteopontin Promotes Mesenchymal Stem Cell Migration and Lessens Cell Stiffness via Integrin β1, FAK, and ERK Pathways. Cell Biochem Biophys 65: 455-462.
59. Weber GF, Cantor H (1996) The immunology of Eta-1/osteopontin. Cytokine Growth Factor Rev 7: 241-248. (Pubitemid 27200308)
60. Georgolios A, Batistatou A, Manolopoulos L, Charalabopoulos K (2006) Role and expression patterns of E-cadherin in head and neck squamous cell carcinoma (HNSCC). J Exp Clin Cancer Res 25: 5-14.
61. Gao C, Guo H, Wei J, Kuo PC (2003) Osteopontin inhibits expression of cytochrome c oxidase in RAW 264.7 murine macrophages. Biochem Biophys Res Commun 309: 120-125. (Pubitemid 36999767)
62. Alper O and Bowden ET (2005) Novel insights into c-Src. Curr Pharm Des 11: 1119-1130. (Pubitemid 40403371)
63. Volberg T, Romer L, Zamir E, Geiger B (2001) pp60 (c-Src) and related tyrosine kinases: a role in the assembly and reorganization of matrix adhesion. J Cell Sci 114: 2279-2289. (Pubitemid 32633699)
64. Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14: 381-395. (Pubitemid 34214843)
65. Bose SK, Meyer K, Di Bisceglie AM, Ray RB, Ray R (2012) Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes. J Virol 86: 13621-13628.
66. Akkari L, Grégoire D, Floc'h N, Moreau M, Hernandez C, et al. (2012) Hepatitis C viral protein NS5A induces EMT and participates in oncogenic transformation of primary hepatocyte precursors. J Hepatol 57: 1021-1028.
67. Hirohashi S (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153: 333-339.
68. Liu YN, Kang BB, Chen JH (2004) Transcriptional regulation of human osteopontin promoter by C/EBPa and AML-1 in metastatic cancer cells. Oncogene 23: 278-288.
69. Wilson GK, Brimacombe CL, Rowe IA, Reynolds GM, Fletcher NF, et al. (2012) A dual role for hypoxia inducible factor-1a in the hepatitis C virus lifecycle and hepatoma migration. J Hepatol 56: 803-809.